Jenny Y. Wang, PhD, is an accomplished researcher in molecular biology, specializing in cancer and stem cell biology. With a background in molecular biology and a PhD from Macquarie University, Sydney, Australia, she currently leads the Cancer and Stem Cell Laboratory at the University of Sydney. Her research focuses on understanding the molecular mechanisms underlying cancer progression and stem cell regulation. Dr. Wang has a strong track record of publications, grant funding, and contributions to conferences, making her a recognized figure in the field.
Author Metrics
Scopus Profile
Dr. Wang has an impressive publication record, with numerous articles published in high-impact journals such as Blood, Cancer Research, Nature Communications, and Leukemia. She has also contributed book chapters and presented abstracts at prestigious conferences, showcasing the breadth and depth of her research contributions. Additionally, she has secured significant grant funding totaling $7.6 million, reflecting the recognition and support her work has received from funding agencies.
- Citations: Jenny Y. Wang has received 2,618 citations across 2,398 documents, indicating the impact and influence of their research in the academic community.
- Documents: Jenny Y. Wang has authored or co-authored 23 documents indexed in the Scopus database.
- h-index: The h-index is a metric that measures both the productivity and citation impact of a researcher’s publications. Jenny Y. Wang has an h-index of 17, suggesting that they have published at least 17 papers that have each been cited at least 17 times.
Education
Dr. Wang earned her PhD in Molecular Biology from Macquarie University, Sydney, Australia, in 2002. Her doctoral research laid the foundation for her subsequent work in cancer and stem cell biology. Throughout her academic journey, she has demonstrated a strong commitment to advancing scientific knowledge and has continuously sought opportunities for professional development and growth.
Research Focus
Dr. Wang’s research primarily focuses on elucidating the molecular mechanisms underlying cancer progression and stem cell regulation. Her work spans various aspects of cancer biology, including cancer stem cells, signaling pathways, epigenetics, and therapeutic strategies. By combining cutting-edge molecular biology techniques with translational approaches, she aims to identify novel therapeutic targets and develop more effective treatments for cancer patients.
Professional Journey
Dr. Wang’s professional journey has been characterized by a series of significant achievements and contributions to the field of molecular oncology. Starting as a Postdoctoral Fellow at prestigious institutions such as Children’s Hospital Boston and Harvard Medical School, she gained valuable experience in cancer research. Subsequently, she transitioned into leadership roles, serving as Lab Head at both the University of New South Wales and the University of Sydney. Throughout her career, she has maintained a strong publication record, secured substantial grant funding, and established collaborations with leading researchers in the field.
Honors & Awards
Dr. Wang has received recognition for her outstanding contributions to cancer research, including honors and awards from prestigious organizations such as the Cancer Council NSW, Leukemia & Lymphoma Society of USA, and National Health and Medical Research Council. These accolades underscore the significance and impact of her research in advancing our understanding of cancer biology and developing new therapeutic approaches.
Publications Noted & Contributions
Dr. Wang’s publications cover a wide range of topics in cancer and stem cell biology, with notable contributions to understanding cancer stem cells, signaling pathways, epigenetics, and therapeutic strategies. Her research has been published in renowned scientific journals, and her work has been cited extensively by her peers, highlighting its significance and influence in the field.
The pan-cancer lncRNA PLANE regulates an alternative splicing program to promote cancer pathogenesis
Authors: Teng, L., Feng, Y.C., Guo, S.T., Shao, F.-M., Zhang, X.D.
Published in: Nature Communications, 2021, 12(1), 3734
Abstract: This study investigates the role of the long non-coding RNA (lncRNA) PLANE in regulating alternative splicing to promote cancer pathogenesis across various cancer types.
Citations: 29
The emerging roles of RNA m6A methylation and demethylation as critical regulators of tumorigenesis, drug sensitivity, and resistance
Authors: Lan, Q., Liu, P.Y., Bell, J.L., Zhang, L., Liu, T.
Published in: Cancer Research, 2021, 81(13), pp. 3431–3440
Abstract: This review explores the emerging roles of RNA m6A methylation and demethylation in regulating various aspects of tumorigenesis, including drug sensitivity and resistance.
Citations: 123
Targeted therapy of TERT-rearranged neuroblastoma with BET bromodomain inhibitor and proteasome inhibitor combination therapy
Authors: Chen, J., Nelson, C., Wong, M., Pickett, H.A., Liu, T.
Published in: Clinical Cancer Research, 2021, 27(5), pp. 1438–1451
Abstract: This article discusses targeted therapy options for TERT-rearranged neuroblastoma using a combination of BET bromodomain inhibitor and proteasome inhibitor therapy.
Citations: 21
Visualization of endogenous p27 and Ki67 reveals the importance of a c-Myc-driven metabolic switch in promoting survival of quiescent cancer cells
Authors: La, T., Chen, S., Guo, T., Zhang, X.D., Jin, L.
Published in: Theranostics, 2021, 11(19), pp. 9605–9622
Abstract: This study visualizes endogenous p27 and Ki67 to elucidate the role of a c-Myc-driven metabolic switch in promoting the survival of quiescent cancer cells.
Citations: 12
An Improved Protocol for Establishment of AML Patient-Derived Xenograft Models
Authors: Hassan, N., Yang, J., Wang, J.Y.
Published in: STAR Protocols, 2020, 1(3), 100156
Abstract: This article presents an improved protocol for establishing patient-derived xenograft models of acute myeloid leukemia (AML).
Citations: 3
Research Timeline
Dr. Wang’s research timeline spans over two decades, starting with her doctoral research in Molecular Biology at Macquarie University. Throughout her career, she has made significant contributions to the field, first as a Postdoctoral Fellow at leading research institutions and later as a Lab Head at prominent universities in Australia. Her research has evolved over time, addressing key questions in cancer biology and stem cell regulation, and she continues to push the boundaries of scientific knowledge through her innovative research endeavors.
Collaborations and Projects
Dr. Wang has established collaborations with leading researchers and institutions worldwide, facilitating interdisciplinary research and knowledge exchange. These collaborations have enabled her to tackle complex research questions and leverage diverse expertise to advance understanding in cancer and stem cell biology. Additionally, she leads various research projects aimed at elucidating the molecular mechanisms driving cancer progression and identifying novel therapeutic targets for improved patient outcomes.
